APOE and dementia: Among White participants, APOE-ε2 carriers at social advantage presented a lower risk of dementia, and APOE-ε4 carriers at social advantage had a greater risk of dementia than APOE-ε3ε3 carriers at social advantage (S10.b Table in S1 File).